|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| A61K 31/47 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3212629 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15837091.6 |
| Date of filing the European patent application | 2015-10-26 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (86) | Number | PCT/IB2015/002438 |
| Date | 2015-10-26 |
| (87) | Number | WO 2016/067112 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| 201462073325 P | 2014-10-31 | US |
| (72) |
BASSISSI, Firas, FR
BERET, Antoine, FR
BRUN, Sonia, FR
COURCAMBECK, Jérōme, FR
DUBRAY, Clarisse, FR
NICOLAS, Gregory, FR
HALFON, Philippe, FR
|
| (73) |
Genoscience Pharma SAS,
10, rue d`Iena, 13006 Marseille,
FR
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pakeistieji 2,4 diamino-chinolinai, kaip nauji priešvėžiniai agentai |
| SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW ANTICANCER AGENTS |
| Payment date | Validity (years) | Amount | |
| 2024-10-23 | 10 | 231.00 EUR |
| 2025-10-26 |